
Latest Health News
Massive Measles Outbreak in South Carolina Hits 933 Cases
South Carolina reports 13 new measles cases, totaling 933, the largest US outbreak in over three decades, mostly in Spartanburg County with 235 in quarantine. A separate eight-case outbreak in California's Shasta County prompts vaccine status checks, first in six years.
Officials investigate sources amid rising concerns.
FDA Rejects Moderna's Flu Vaccine Application
The FDA refused to review Moderna's flu vaccine application, signaling regulatory hurdles for new vaccines. Meanwhile, the AMA launched its own evidence-based review of flu, COVID-19, and RSV vaccines with CIDRAP, critiquing federal processes.
This aims to ensure safety and efficacy independently.
IRBM Achieves Breakthrough Zika Virus Protease Inhibitor
IRBM discovered a novel allosteric inhibitor for Zika virus NS2B-NS3 protease, showing strong antiviral activity in preclinical models. The molecule offers potential against other flaviviruses like dengue and has a favorable safety profile.
Published in Nature Communications, it addresses urgent needs for ZIKV treatments.
WHO Urges Action: Half of Cataract-Blind People Lack Surgery Access
Nearly half of people worldwide facing cataract-related blindness need access to sight-restoring surgery, per a new Lancet study. WHO calls for accelerating efforts to address inequities and prioritize underserved groups.
Cataract surgery is affordable and effective against avoidable blindness.
Ropeginterferon Alfa-2b Outperforms in High-Risk Blood Cancer Trial
Global SURPASS-ET trial shows ropeginterferon alfa-2b superior to anagrelide for high-risk essential thrombocythemia patients intolerant to hydroxyurea. It improves blood counts, symptoms, and reduces complications.
FDA accepted expansion application, review due by August.
NIH Creates Digital Twin of Eye Cells for AMD Research
NIH developed a subcellular-resolution digital twin of retinal pigment epithelial cells to study age-related macular degeneration (AMD). It reveals how cells lose polarity in disease, aiding therapeutic discovery.
The AI-driven atlas could extend to other conditions affecting cell polarity.
CREST-2 Trial: Stenting Halves Stroke Risk with Medical Management
CREST-2 trial with over 2,400 patients shows carotid stenting plus top medical management reduces stroke risk by half for severe artery narrowing. This advances prevention beyond lifestyle and drugs alone.
Pathways are being streamlined for early patient identification.
Polls: 90% of Americans Support Vaccine Access and US Science Leadership
Surveys show 90% of Americans want ensured vaccine access and 91% back US global leadership in medical progress, bipartisan support. This underscores public demand despite political divides.
Partnership to Fight Infectious Disease and Research!America conducted the polls.